Biocompatible Spherical Gold Nanoparticles Synthesis in Aqueous Tetraethylene Oxide Solution and Their Cellular Uptake.


Journal

Journal of nanoscience and nanotechnology
ISSN: 1533-4880
Titre abrégé: J Nanosci Nanotechnol
Pays: United States
ID NLM: 101088195

Informations de publication

Date de publication:
01 07 2019
Historique:
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 5 6 2021
Statut: ppublish

Résumé

Small well-defined spherical gold nanoparticles were synthesized by a simple non-physical method based on a mixture of gold salt, tetraethylene oxide and water, free of any additional reducing chemical agent or physical method. The ratio of tetraethylene oxide to water was optimized to achieve a fast synthesis within 30 min. Transmission electron microscopy images showed well dispersed gold nanospheres with a size ranging from 10 to 15 nm. XPS was used to confirm the oxidation state of gold nanoparticles and the oxidation products from tetraethylene oxide after the reaction. This new protocol performed in sustainable and biocompatible conditions is complementary to the current methods used to synthesize gold nanospheres. In order to use these particles in biological samples, we correlated the atomic absorption with the colorimetric concentration of nanospheres in solution. After 24 h of incubation of cancer or neuronal cell lines with these nanoparticles, transmission electron microscopy images showed similar cellular uptake in both cell lines, especially in cytoplasmic vesicular structures.

Identifiants

pubmed: 30764930
doi: 10.1166/jnn.2019.16304
doi:

Substances chimiques

Gold Compounds 0
Oxides 0
Water 059QF0KO0R
Gold 7440-57-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3744-3754

Auteurs

Anne Juliette Trouiller (AJ)

University of Poitiers, IC2MP UMR 7285 CNRS, 4 rue Michel Brunet B27, TSA 51106, 86073 Poitiers cedex 9, France.

Emile Béré (E)

INSERM U1084, Experimental and Clinical Neurosciences Laboratory, Cellular Therapies in Brain Diseases Group, University of Poitiers, 1 rue Georges Bonnet, TSA 51106, 86073 Poitiers cedex 9, France.

Joanna Kalaani (J)

INSERM U1084, Experimental and Clinical Neurosciences Laboratory, Cellular Therapies in Brain Diseases Group, University of Poitiers, 1 rue Georges Bonnet, TSA 51106, 86073 Poitiers cedex 9, France.

Emilie Evanno (E)

University of Poitiers, UFR/SFA, Pôle Biologie Santé, Bâtiment B36/37, 1 rue Georges Bonnet, TSA 51106, 86073 Poitiers cedex 9, France.

Benoit Fouchaq (B)

Eurofins-Cerep, Le Bois l'Evêque, 86600 Celle - L'Evescault, France.

Joëlle Roche (J)

University of Poitiers, UFR/SFA, Pôle Biologie Santé, Bâtiment B36/37, 1 rue Georges Bonnet, TSA 51106, 86073 Poitiers cedex 9, France.

Laetitia Prestoz (L)

INSERM U1084, Experimental and Clinical Neurosciences Laboratory, Cellular Therapies in Brain Diseases Group, University of Poitiers, 1 rue Georges Bonnet, TSA 51106, 86073 Poitiers cedex 9, France.

Teko W Napporn (TW)

University of Poitiers, IC2MP UMR 7285 CNRS, 4 rue Michel Brunet B27, TSA 51106, 86073 Poitiers cedex 9, France.

Philippe Bertrand (P)

University of Poitiers, IC2MP UMR 7285 CNRS, 4 rue Michel Brunet B27, TSA 51106, 86073 Poitiers cedex 9, France.

Articles similaires

Humans Hyaluronic Acid Osteoarthritis, Hip Female Middle Aged
Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
1.00
Oryza Agricultural Irrigation Potassium Sodium Soil

Classifications MeSH